These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3797342)

  • 1. Passive avoidance deficit following intracerebroventricular administration of cholecystokinin tetrapeptide amide in rats.
    Katsuura G; Itoh S
    Peptides; 1986; 7(5):809-14. PubMed ID: 3797342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive effect of cholecystokinin octapeptide on experimental amnesia in rats.
    Katsuura G; Itoh S
    Peptides; 1986; 7(1):105-10. PubMed ID: 3714527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cholecystokinin-related peptides on retention of passive avoidance behaviour.
    Fekete M; Penke B; Telegdy G
    Acta Physiol Acad Sci Hung; 1982; 60(4):237-42. PubMed ID: 6314742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversed behavioral effect of cholecystokinin after frontal decortication in rats.
    Itoh S; Katsuura G; Itoh T; Morimoto T
    Life Sci; 1994; 55(11):PL213-6. PubMed ID: 8072383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral effects of cholecystokinin and its related peptides in rats.
    Itoh S; Katsuura G
    Prog Clin Biol Res; 1985; 192():139-45. PubMed ID: 2934743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of cholecystokinin, beta-endorphin, and their antagonists on passive avoidance behavior in rats.
    Itoh S; Katsuura G; Takashima A
    Can J Physiol Pharmacol; 1987 Nov; 65(11):2260-4. PubMed ID: 2966663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cholecystokinin tetrapeptide amide on the metabolism of 5-hydroxytryptamine in the rat brain.
    Itoh S; Takashima A; Katsuura G
    Neuropharmacology; 1988 Apr; 27(4):427-31. PubMed ID: 2458532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinociceptive action of cholecystokinin octapeptide (CCK 8) and related peptides in rats and mice: effects of naloxone and peptidase inhibitors.
    Hill RG; Hughes J; Pittaway KM
    Neuropharmacology; 1987 Apr; 26(4):289-300. PubMed ID: 3295578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of passive avoidance behaviour of rats by intracerebroventricular administration of cholecystokinin octapeptide sulfate ester and nonsulfated cholecystokinin octapeptide.
    Kádár T; Fekete M; Telegdy G
    Acta Physiol Acad Sci Hung; 1981; 58(4):269-74. PubMed ID: 6291322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of nucleus accumbens to activities related to cholecystokinins in rats.
    Katsuura G; Itoh S; Hsiao S
    Peptides; 1985; 6(1):91-6. PubMed ID: 3991366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered responding to cholecystokinins and dopaminergic agonists following 6-hydroxydopamine treatment in rats.
    Hsiao S; Katsuura G; Itoh S
    Behav Neurosci; 1985 Oct; 99(5):853-60. PubMed ID: 3939625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of sulfated and nonsulfated cholecystokinin octapeptides on electroconvulsive shock-induced retrograde amnesia after intracerebroventricular administration in rats.
    Kádár T; Penke B; Kovács K; Telegdy G
    Neuropeptides; 1984 Mar; 4(2):127-35. PubMed ID: 6325992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further analysis of the effects of cholecystokinin octapeptides on avoidance behaviour in rats.
    Fekete M; Lengyel A; Hegedüs B; Penke B; Zarándy M; Tóth G; Telegdy G
    Eur J Pharmacol; 1984 Feb; 98(1):79-91. PubMed ID: 6325212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Memory effect of caerulein and its analogs in active and passive avoidance responses in the rat.
    Itoh S; Takashima A; Igano K; Inouye K
    Peptides; 1989; 10(4):843-8. PubMed ID: 2531375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracerebroventricular injections of cholecystokinin octapeptide suppress feeding in rats--pharmacological characterization of this action.
    Schick RR; Yaksh TL; Go VL
    Regul Pept; 1986 Jul; 14(4):277-91. PubMed ID: 3749526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholecystokinin octapeptide increases passive avoidance latencies in rats.
    Deupree D; Hsiao S
    Physiol Behav; 1988; 42(2):203-5. PubMed ID: 3368541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of sulfated cholecystokinin octapeptide and cholecystokinin tetrapeptide in rat behavior after blockade of nitric oxide synthase by L-NAME.
    Hoły Z; Wiśniewski K
    Rocz Akad Med Bialymst; 1998; 43():250-70. PubMed ID: 9972062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of memory, reinforcement and anxiety parameters by intra-amygdala injection of cholecystokinin-fragments Boc-CCK-4 and CCK-8s.
    Huston JP; Schildein S; Gerhardt P; Privou C; Fink H; Hasenöhrl RU
    Peptides; 1998; 19(1):27-37. PubMed ID: 9437734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central injections of arginine vasopressin prolong extinction of active avoidance.
    Koob GF; Dantzer R; Bluthé RM; Lebrun C; Bloom FE; Le Moal M
    Peptides; 1986; 7(2):213-8. PubMed ID: 3737445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for central neuropeptidergic control of rumination in sheep.
    Honde C; Bueno L
    Peptides; 1984; 5(1):81-3. PubMed ID: 6324151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.